Evidence map›Paper›PMID 32740239›Full record

ArticleAnnals of surgery2020

Predictors of Survival After Liver Transplantation in Patients With the Highest Acuity (MELD ≥40).

Michael D Evans, Jessica Diaz, Anna M Adamusiak, Timothy L Pruett, Varvara A Kirchner, Raja Kandaswamy, Vanessa R Humphreville, Thomas M Leventhal, Jeffrey O Grosland, David M Vock and 2 more

Abstract read
In one paragraph

Article in Annals of surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Consequences of low estimated glomerular filtration rate either before or early after kidney donation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2024
    Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Michael D EvansClinical and Translational Science Institute, University of Minnesota Medical School, Minneapolis, Minnesota.
Jessica DiazDivision of Transplantation, Department of Surgery, University of Minnesota Medical School, Minneapolis, Minnesota.
Anna M AdamusiakDivision of Transplantation, Department of Surgery, University of Minnesota Medical School, Minneapolis, Minnesota.
Timothy L PruettDivision of Transplantation, Department of Surgery, University of Minnesota Medical School, Minneapolis, Minnesota.
Varvara A KirchnerDivision of Transplantation, Department of Surgery, University of Minnesota Medical School, Minneapolis, Minnesota.
Raja KandaswamyDivision of Transplantation, Department of Surgery, University of Minnesota Medical School, Minneapolis, Minnesota.
Vanessa R HumphrevilleDivision of Transplantation, Department of Surgery, University of Minnesota Medical School, Minneapolis, Minnesota.
Thomas M LeventhalDepartment of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota.
Jeffrey O GroslandDepartment of Anesthesiology, University of Minnesota Medical School, Minneapolis, Minnesota.
David M VockClinical and Translational Science Institute, University of Minnesota Medical School, Minneapolis, Minnesota.
Arthur J MatasDivision of Transplantation, Department of Surgery, University of Minnesota Medical School, Minneapolis, Minnesota.
Srinath ChinnakotlaDivision of Transplantation, Department of Surgery, University of Minnesota Medical School, Minneapolis, Minnesota.

Funding

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
NCATS NIH HHS UL1 TR002494
6 · The paper itself

Abstract

objectiveTo identify factors that accurately predict 1-year survival for liver transplant recipients with a MELD score ≥40.

backgroundAlthough transplant is beneficial for patients with the highest acuity (MELD ≥40), mortality in this group is high. Predicting which patients are likely to survive for >1 year would be medically and economically helpful.

methodsThe Scientific Registry of Transplant Recipients database was reviewed to identify adult liver transplant recipients from 2002 through 2016 with MELD score ≥40 at transplant. The relationships between 44 recipient and donor factors and 1-year patient survival were examined using random survival forests methods. Variable importance measures were used to identify the factors with the strongest influence on survival, and partial dependence plots were used to determine the dependence of survival on the target variable while adjusting for all other variables.

resultsWe identified 5309 liver transplants that met our criteria. The overall 1-year survival of high-acuity patients improved from 69% in 2001 to 87% in 2016. The strongest predictors of death within 1 year of transplant were patient on mechanical ventilator before transplantation, prior liver transplant, older recipient age, older donor age, donation after cardiac death, and longer cold ischemia.

conclusionsLiver transplant outcomes continue to improve even for patients with high medical acuity. Applying ensemble learning methods to recipient and donor factors available before transplant can predict survival probabilities for future transplant cases. This information can be used to facilitate donor/recipient matching and to improve informed consent.

Indexed as

Tissue DonorsTransplant RecipientsCold IschemiaEnd Stage Liver DiseaseFemaleFollow-Up StudiesGraft SurvivalHumansLiver TransplantationMaleMiddle AgedPrognosisRetrospective StudiesSurvival RateTissue and Organ ProcurementUnited States

Identifiers

PMID32740239
PMCPMC7855276

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.